Screener
Amylyx Pharmaceuticals, Inc. AMLX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | 14,438 | 14,183 |
| Depreciation expense | 141 | 297 |
| Accretion of investment discounts, net | (1,826) | (3,226) |
| Charge for in-process research and development ("IPR&D") milestones | 4,000 | — |
| Other non-cash items | 84 | 264 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | 1,108 | 6,941 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported accretion (amortization) of discounts and premiums, investments of $1.22M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 20.1% year-over-year, from $1.52M to $1.22M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 39.0% compound annual growth rate (CAGR), from $2.06M to $5.53M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to net income resulting from the amortization of premiums or the accretion of discounts on investment securities held by the company. It reconciles the difference between the purchase price of debt securities and their face value over the holding period. This adjustment is essential for accurately reflecting the effective interest income earned on the investment portfolio.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude